 | • レポートコード：QY2207C3462 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のガンマアミノ酪酸（GABA）受容体アゴニストの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にガンマアミノ酪酸（GABA）受容体アゴニストの世界市場のxxx％を占める「経口」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のガンマアミノ酪酸（GABA）受容体アゴニストの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのガンマアミノ酪酸（GABA）受容体アゴニスト市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのガンマアミノ酪酸（GABA）受容体アゴニスト市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ガンマアミノ酪酸（GABA）受容体アゴニストのグローバル主要メーカーには、Sanofi、Mylan N.V.、Teva Pharmaceutical Industries、Novartis、Aytu BioScience、Dr. Reddy’s Laboratories、Endo Pharmaceuticals、Lupin、Johnson & Johnson Services、Lannett、Sun Pharmaceutical Industries、Cipla、Aurobindo Pharma、Zydus Cadilaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ガンマアミノ酪酸（GABA）受容体アゴニスト市場は、種類と用途によって区分されます。世界のガンマアミノ酪酸（GABA）受容体アゴニスト市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口、非経口、髄腔内、その他 【用途別セグメント】 病院、専門クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ガンマアミノ酪酸（GABA）受容体アゴニスト製品概要 - 種類別市場（経口、非経口、髄腔内、その他） - 用途別市場（病院、専門クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のガンマアミノ酪酸（GABA）受容体アゴニスト販売量予測2017-2028 - 世界のガンマアミノ酪酸（GABA）受容体アゴニスト売上予測2017-2028 - ガンマアミノ酪酸（GABA）受容体アゴニストの地域別販売量 - ガンマアミノ酪酸（GABA）受容体アゴニストの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ガンマアミノ酪酸（GABA）受容体アゴニスト販売量 - 主要メーカー別ガンマアミノ酪酸（GABA）受容体アゴニスト売上 - 主要メーカー別ガンマアミノ酪酸（GABA）受容体アゴニスト価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口、非経口、髄腔内、その他） - ガンマアミノ酪酸（GABA）受容体アゴニストの種類別販売量 - ガンマアミノ酪酸（GABA）受容体アゴニストの種類別売上 - ガンマアミノ酪酸（GABA）受容体アゴニストの種類別価格 ・用途別市場規模（病院、専門クリニック、その他） - ガンマアミノ酪酸（GABA）受容体アゴニストの用途別販売量 - ガンマアミノ酪酸（GABA）受容体アゴニストの用途別売上 - ガンマアミノ酪酸（GABA）受容体アゴニストの用途別価格 ・北米市場 - 北米のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（種類別、用途別） - 主要国別のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（種類別、用途別） - 主要国別のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（種類別、用途別） - 主要国別のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（種類別、用途別） - 主要国別のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（種類別、用途別） - 主要国別のガンマアミノ酪酸（GABA）受容体アゴニスト市場規模（トルコ、サウジアラビア） ・企業情報 Sanofi、Mylan N.V.、Teva Pharmaceutical Industries、Novartis、Aytu BioScience、Dr. Reddy’s Laboratories、Endo Pharmaceuticals、Lupin、Johnson & Johnson Services、Lannett、Sun Pharmaceutical Industries、Cipla、Aurobindo Pharma、Zydus Cadila ・産業チェーン及び販売チャネル分析 - ガンマアミノ酪酸（GABA）受容体アゴニストの産業チェーン分析 - ガンマアミノ酪酸（GABA）受容体アゴニストの原材料 - ガンマアミノ酪酸（GABA）受容体アゴニストの生産プロセス - ガンマアミノ酪酸（GABA）受容体アゴニストの販売及びマーケティング - ガンマアミノ酪酸（GABA）受容体アゴニストの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ガンマアミノ酪酸（GABA）受容体アゴニストの産業動向 - ガンマアミノ酪酸（GABA）受容体アゴニストのマーケットドライバー - ガンマアミノ酪酸（GABA）受容体アゴニストの課題 - ガンマアミノ酪酸（GABA）受容体アゴニストの阻害要因 ・主な調査結果 |
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
Market Analysis and Insights: Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market
The global Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oral accounting for % of the Gamma-aminobutyric Acid (GABA) Receptor Agonist global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is valued at US$ million in 2021, while the North America and Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market.
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Scope and Market Size
Gamma-aminobutyric Acid (GABA) Receptor Agonist market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Parenteral
Intrathecal
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Company
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla
Aurobindo Pharma
Zydus Cadila
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Intrathecal
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Perspective (2017-2028)
2.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Growth Trends by Region
2.2.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Region (2017-2022)
2.2.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Region (2023-2028)
2.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics
2.3.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Industry Trends
2.3.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers
2.3.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Challenges
2.3.4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Revenue
3.1.1 Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Revenue (2017-2022)
3.1.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Players (2017-2022)
3.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue
3.4 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Concentration Ratio
3.4.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2021
3.5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Key Players Head office and Area Served
3.6 Key Players Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Solution and Service
3.7 Date of Enter into Gamma-aminobutyric Acid (GABA) Receptor Agonist Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Breakdown Data by Type
4.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Type (2017-2022)
4.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Type (2023-2028)
5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Breakdown Data by Application
5.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Application (2017-2022)
5.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
6.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type
6.2.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
6.2.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2023-2028)
6.2.3 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Type (2017-2028)
6.3 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application
6.3.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
6.3.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2023-2028)
6.3.3 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application (2017-2028)
6.4 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
6.4.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
6.4.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
7.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type
7.2.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
7.2.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2023-2028)
7.2.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Type (2017-2028)
7.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application
7.3.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
7.3.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2023-2028)
7.3.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application (2017-2028)
7.4 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
7.4.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
7.4.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
8.2 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type
8.2.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Type (2017-2028)
8.3 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application
8.3.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application (2017-2028)
8.4 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region
8.4.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
9.2 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type
9.2.1 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
9.2.2 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2023-2028)
9.2.3 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Type (2017-2028)
9.3 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application
9.3.1 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
9.3.2 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2023-2028)
9.3.3 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application (2017-2028)
9.4 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
9.4.1 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
9.4.2 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2017-2028)
10.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type
10.2.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Type (2017-2028)
10.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application
10.3.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application (2017-2028)
10.4 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
10.4.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.1.4 Sanofi Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Details
11.2.2 Mylan N.V. Business Overview
11.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.2.4 Mylan N.V. Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.2.5 Mylan N.V. Recent Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.3.5 Teva Pharmaceutical Industries Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.4.4 Novartis Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Aytu BioScience
11.5.1 Aytu BioScience Company Details
11.5.2 Aytu BioScience Business Overview
11.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.5.4 Aytu BioScience Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.5.5 Aytu BioScience Recent Developments
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Company Details
11.6.2 Dr. Reddy’s Laboratories Business Overview
11.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.6.4 Dr. Reddy’s Laboratories Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.6.5 Dr. Reddy’s Laboratories Recent Developments
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Details
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.7.4 Endo Pharmaceuticals Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.7.5 Endo Pharmaceuticals Recent Developments
11.8 Lupin
11.8.1 Lupin Company Details
11.8.2 Lupin Business Overview
11.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.8.4 Lupin Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.8.5 Lupin Recent Developments
11.9 Johnson & Johnson Services
11.9.1 Johnson & Johnson Services Company Details
11.9.2 Johnson & Johnson Services Business Overview
11.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.9.4 Johnson & Johnson Services Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.9.5 Johnson & Johnson Services Recent Developments
11.10 Lannett
11.10.1 Lannett Company Details
11.10.2 Lannett Business Overview
11.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.10.4 Lannett Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.10.5 Lannett Recent Developments
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Company Details
11.11.2 Sun Pharmaceutical Industries Business Overview
11.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.11.4 Sun Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.11.5 Sun Pharmaceutical Industries Recent Developments
11.12 Cipla
11.12.1 Cipla Company Details
11.12.2 Cipla Business Overview
11.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.12.4 Cipla Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.12.5 Cipla Recent Developments
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Company Details
11.13.2 Aurobindo Pharma Business Overview
11.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.13.4 Aurobindo Pharma Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.13.5 Aurobindo Pharma Recent Developments
11.14 Zydus Cadila
11.14.1 Zydus Cadila Company Details
11.14.2 Zydus Cadila Business Overview
11.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.14.4 Zydus Cadila Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2017-2022)
11.14.5 Zydus Cadila Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer